×
About 25,283 results

ALLMedicine™ Renal Cell Carcinoma Center

Research & Reviews  8,493 results

Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523177/
Journal of Kidney Cancer and VHL; Lin J

Oct 13th, 2021 - Advance diagnostic and treatment modalities have improved outcomes for renal cell carcinoma (RCC) patients, but the prognosis for those with metastatic disease (mRCC) remains poor. As given metastatic distribution is critical in guiding treatment ...

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing
https://pubmed.ncbi.nlm.nih.gov/34654685/
European Urology Oncology; Truong H

Oct 12th, 2021 - Despite guidelines recommending genetic counseling for patients with early-onset renal cell carcinoma (RCC), studies interrogating the spectrum of germline mutations and clinical associations in patients with early-onset RCC are lacking.

Studying the association between breast cancer and renal cell carcinoma.
https://doi.org/10.1007/s10549-021-06465-4 10.2741/4230 10.1002/cncr.21051 10.3109/02841869409121767 10.7860/JCDR/2016/20362.8683 10.1155/2019/6246209 10.1007/s12262-013-1031-0 10.4236/jct.2018.911075 10.3332/ECANCER.2020.1120 10.1111/j.1464-410X.2006.06004.x 10.4274/uob.galenos.2020.1785 10.1016/J.EJCA.2008.10.026 10.3390/CELLS9122675
Breast Cancer Research and Treatment; Jazieh K, Baidoun F et. al.

Dec 3rd, 2021 - There are case reports of patients with both primary breast cancer (BC) and renal cell carcinoma (RCC). We explore the association between these two malignancies using SEER population data and our institutional records. We studied the association ...

see more →

Guidelines  19 results

Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523177/
Journal of Kidney Cancer and VHL; Lin J

Oct 13th, 2021 - Advance diagnostic and treatment modalities have improved outcomes for renal cell carcinoma (RCC) patients, but the prognosis for those with metastatic disease (mRCC) remains poor. As given metastatic distribution is critical in guiding treatment ...

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing
https://pubmed.ncbi.nlm.nih.gov/34654685/
European Urology Oncology; Truong H

Oct 12th, 2021 - Despite guidelines recommending genetic counseling for patients with early-onset renal cell carcinoma (RCC), studies interrogating the spectrum of germline mutations and clinical associations in patients with early-onset RCC are lacking.

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and ...
https://doi.org/10.1016/j.annonc.2021.09.014
Annals of Oncology : Official Journal of the European Soc... Powles T, Albiges L et. al.

Oct 2nd, 2021 - ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma.|2021|Powles T,Albiges L,Bex A,Grünwald V,Porta C,|drug therapy,drug therapy,

NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
https://doi.org/10.6004/jnccn.2020.0043
Journal of the National Comprehensive Cancer Network : JN... Motzer RJ, Jonasch E et. al.

Sep 5th, 2020 - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, in...

Percutaneous microwave ablation of renal cell carcinoma: practice guidelines of the ult...
https://doi.org/10.1080/02656736.2020.1779356
International Journal of Hyperthermia : the Official Jour... Yu J, Yu XL et. al.

Jul 9th, 2020 - Imaging-guided percutaneous microwave ablation (MWA) with high thermal efficiency comprises rapid, successful management of small renal cell carcinomas (RCCs) in selected patients. Ultrasound Committee of Chinese Medical Association, Interventiona...

see more →

Drugs  39 results see all →

Clinicaltrials.gov  351 results

Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523177/
Journal of Kidney Cancer and VHL; Lin J

Oct 13th, 2021 - Advance diagnostic and treatment modalities have improved outcomes for renal cell carcinoma (RCC) patients, but the prognosis for those with metastatic disease (mRCC) remains poor. As given metastatic distribution is critical in guiding treatment ...

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing
https://pubmed.ncbi.nlm.nih.gov/34654685/
European Urology Oncology; Truong H

Oct 12th, 2021 - Despite guidelines recommending genetic counseling for patients with early-onset renal cell carcinoma (RCC), studies interrogating the spectrum of germline mutations and clinical associations in patients with early-onset RCC are lacking.

Pembrolizumab With or Without Axitinib for Treatment of Locally Advanced or Metastatic Clear Cell Kidney Cancer in Patients Undergoing Surgery
https://clinicaltrials.gov/ct2/show/NCT04370509

Nov 22nd, 2021 - PRIMARY OBJECTIVE: I. To determine the impact of pembrolizumab-based therapy on the composition, phenotype, and function of tumor-infiltrating immune cells (TIICs) in subjects with advanced renal cell carcinoma (RCC) undergoing cytoreductive nephr...

A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment
https://clinicaltrials.gov/ct2/show/NCT04338269

Nov 22nd, 2021 - This is a Phase III, multicenter, randomized, open-label study designed to evaluate the efficacy and safety of atezolizumab given in combination with cabozantinib versus cabozantinib alone in participants with inoperable, locally advanced, or meta...

MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma
https://clinicaltrials.gov/ct2/show/NCT02724020

Nov 19th, 2021 - The drugs being tested in this study are called MLN0128 and MLN1117. MLN0128 and MLN1117 are being tested to treat people who have mccRCC. This study will assess the efficacy and safety of MLN0128 and MLN1117 as well as how it is processed by the ...

see more →

News  1,206 results

Evolving Patterns of Metastasis in Renal Cell Carcinoma: Do We Need to Perform Routine Bone Imaging?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523177/
Journal of Kidney Cancer and VHL; Lin J

Oct 13th, 2021 - Advance diagnostic and treatment modalities have improved outcomes for renal cell carcinoma (RCC) patients, but the prognosis for those with metastatic disease (mRCC) remains poor. As given metastatic distribution is critical in guiding treatment ...

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing
https://pubmed.ncbi.nlm.nih.gov/34654685/
European Urology Oncology; Truong H

Oct 12th, 2021 - Despite guidelines recommending genetic counseling for patients with early-onset renal cell carcinoma (RCC), studies interrogating the spectrum of germline mutations and clinical associations in patients with early-onset RCC are lacking.

Half of VHL-Associated Kidney Tumors Respond to HIF2A Inhibitor
https://www.medpagetoday.com/hematologyoncology/renalcellcarcinoma/95891

Nov 26th, 2021 - Treatment with belzutifan (Welireg), a small-molecule hypoxia-inducible factor 2α (HIF2A) inhibitor, induced strong responses in patients whose cancers were associated with von Hippel-Lindau (VHL) disease, investigators reported. In a phase II stu...

Investigators Set Their Sets on Novel Targets in Genitourinary Malignancies
https://www.onclive.com/view/investigators-set-their-sets-on-novel-targets-in-genitourinary-malignancies

Nov 24th, 2021 - With an abundance of combination strategies in frontline metastatic renal cell carcinoma (RCC) and maintenance immunotherapy in advanced urothelial carcinoma that have shown overall survival (OS) benefits, research has turned to developing a more ...

Dr. Bupathi on Considerations for Second-Line Sequencing in RCC
https://www.onclive.com/view/dr-bupathi-on-considerations-for-second-line-sequencing-in-rcc

Nov 23rd, 2021 - Manojkumar Bupathi, MD, MS, medical oncologist, Rocky Mountain Cancer Centers, discusses considerations for second-line treatment sequencing in clear cell renal cell carcinoma (RCC). A main consideration in sequencing therapy for patients with RC...

see more →

Patient Education  5 results see all →